Home

Nicholas Lydon

CIK 1639935 · last filed 2024-06-14

Nicholas Lydon is a corporate insider who has filed 28 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for BPMC, was dated Jun 14, 2024. Across all open-market trades the lifetime net is −$16.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $15.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.48M

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$16.45M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Blueprint Medicines Corp (BPMC) Delisted Director 58,026 $129.46 $7.51M -$13.83M 22 2024-06-14
ANAB Director 276,131 $56.07 $15.48M -$2.62M 6 2019-02-11

Recent Filings

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-14 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +2,242 $0 EDGAR
2023-06-23 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +2,600 $0 EDGAR
2022-06-30 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +2,600 $0 EDGAR
2022-05-25 Blueprint Medicines Corp (BPMC) Delisted Exer (M) +10,909 $213.1K EDGAR
2021-06-04 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +2,250 $0 EDGAR
2020-10-05 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −9,815 -$913.6K EDGAR
2020-09-21 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −500 -$40.0K EDGAR
2020-07-08 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −26,007 -$2.09M EDGAR
2020-07-06 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −4,125 -$330.6K EDGAR
2020-06-26 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +2,250 $0 EDGAR
Showing 1–10 of 28
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.